Are you interested in sponsoring the 2018 ACNS Conference? Download our Sponsorship and Exhibition Prospectus or contact Nicholas van Dam.
g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria, from developing the first commercial Brain-Computer Interface (BCI) system. Followed by years of research and development, g.tec became one of the leaders in the fields of BCI, medical devices, neurotechnology, and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), New York (USA), and Hong Kong. g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery (MI) and evoked potentials (EP). Thus, all hardware and software with g.tec’s BCI technology can be used in clinical environments or for research purposes. What’s more, g.tec is an active member in national and international research projects and scientific publishing around the world.
In addition to research products, g.tec offers CE-certified and FDA-cleared clinical systems that can be used in hospitals, rehabilitation centers or operating rooms.
- recoveriX – motor rehabilitation after stroke
- mindBEAGLE – brain assessment and communication
- cortiQ – brain mapping for the operating room & neuro monitoring unit
- Unicorn – the brain interface
Find the better solution for your needs. Take advantage of our experience!
Symbiotic Devices services Australia and New Zealand, providing both innovative, best-in-class technologies, and technical and scientific support, for EEG/ERP/EP, TMS, tDCS/HD-tDCS, fNIRS, EMG, NCS, IONM and BCI and integrated solutions for combined measurements with fMRI, fNIRS, TMS, MEG and tDCS. Symbiotic Devices’ business is anchored in its core values of providing a benefit to our clinical and research communities through technology and support, and contributing to a sustainable and successful research and clinical sector in Australia and New Zealand. Symbiotic Devices proudly represents Cadwell, Brain Products, EasyCap, Rogue Research and Rogue Resolutions, CED, Deymed, NeuroConn/NeuroCare, Rhythmlink, Pearl Technology, VPixx and Artinis.
Cancer Council Victoria is a non-profit cancer charity organisation involved in cancer research, patient support, cancer prevention and advocacy. Every year, more than 30 500 Victorians will be diagnosed with cancer, and nearly 11 000 will die from cancer. The number of cases will increase as our population grows and ages. Survival will also improve as we get better at early detection and treatment of cancer. Since our establishment in 1936, Cancer Council Victoria has developed an international reputation for our innovative work in cancer research, prevention and support. As an independent, not-for-profit organisation, we play a leading role in reducing the impact of all cancers on all people.
The Centre of Excellence for Integrative Brain Function will address one of the greatest scientific challenges of the 21st century – to understand how the brain works. We will investigate complex functions such as attention, prediction and decision-making, which require the coordination of information processing by many areas of the brain. This will require a highly collaborative approach involving neurobiologists, cognitive scientists, engineers and physicists, allowing us to translate our discoveries into novel technologies for the social and economic benefit of all Australians. We will also train a new generation of multidisciplinary researchers, and contribute our expertise to a range of public education and awareness programs.
Compumedics Neuroscan, the brain research division of Australian listed Compumedics Limited, is dedicated to expanding knowledge and understanding of the human brain and nervous system through advanced technology. Compumedics Neuroscan is a world-leading developer of research software for neurophysiology, neuroimaging, and neurodiagnostic systems. Neuroscan provides tools to increase understanding and improve treatment of this most complex and least understood system of the human body: the brain.
Medilink Australia offers a range of innovative neuro stimulation and modulation devices as well as medical imaging hardware, software and consumables to the healthcare market within Australia. Medilink is based in Sydney and has been operational for over 25 years, distributing premium brand scientific instrumentation to clinical and research markets throughout Australia and New Zealand. We supply and service a selection of products that support Neuroscience research, education and therapy through Neuro-diagnostics, Neuro-modulation, Neuro-stimulation, Neuro-imaging and Neuro-navigation. We also provide a range of medical imaging hardware, software and consumables.
The Monash Institute of Cognitive and Clinical Neurosciences (MICCN) is the largest Institute of its type in the Asia Pacific, uniting over 200 world-class researchers with cutting-edge research infrastructure. We are dedicated to understanding the brain and mind; specifically in addiction, attention and memory, and sleep. Our research and education programs are delivered in collaboration with clinical and industry partners.
NEUROSPEC AG is a global distributor of computer-based diagnostic and research equipment (including accessories) to Neurology, Audiology, Neuropsychology, Psychophysiology and Research markets. NEUROSPEC AG provides cutting-edge technology from world-class manufacturers at competitive prices and continues to expand into several related market sectors, e.g. neurological diagnostics, monitoring, sleep disorders, audiological neurology including OAE’s and DP’s and Research EEG/BCI/ERP applications.